循环长非编码7SRNA与深静脉血栓形成的关联
Xiao Wang1, Ashfaque A Memon1, Anna Hedelius1
1Department of Clinical Sciences, Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.
Seminars in thrombosis and hemostasis
|August 23, 2023
概括
在患有深静脉血栓症 (DVT) 的患者中发现了较低水平的7SRNA,一种线粒体长非编码RNA. 这表明7SRNA可能成为诊断DVT的潜在生物标志物.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 血管医学 血管医学
背景情况:
- 线粒体功能障碍与深静脉血栓 (DVT) 病原发生有关.
- 对于线粒体功能至关重要的长非编码RNA-7SRNA在DVT中的特定作用尚不清楚.
研究的目的:
- 研究7SRNA作为深静脉血栓症 (DVT) 的诊断生物标记物的潜力.
主要方法:
- 使用定量实时PCR测量237名怀疑患有DVT的患者的血7SRNA水平.
- 进行了统计分析,包括线性回归和ROC曲线分析.
主要成果:
- 与非DVT对照组相比,患有DVT的患者的血7SRNA表达显着较低 (0.50对0.95,p=0.043).
- 下7SRNA和DVT之间的关联仍然显著,并且独立于混因子 (β = -0.72,p = 0.007).
- 接收器运行特征分析给出了7SRNA的0.60曲线下的面积.
结论:
- 血7SRNA水平降低和深静脉血栓塞 (DVT) 之间存在着显著的关联.
- 需要进一步的研究来澄清7SRNA在DVT病理生理学中的确切作用,并确认其诊断效用.
相关概念视频
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K


